fda bpc 157 category 2 bulk drug substance list has removed certain substances that were placed on the two and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA advisers back first four
FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
